Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
120 participants
OBSERVATIONAL
2020-03-17
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nocturnal Blood Pressure and Hypertension - Central and Peripheral 24-h Blood Pressure.
NCT02078765
Nocturnal Blood Pressure Dipping and Ventricular Repolarization in Hypertension
NCT07200856
Nocturnal Hypertension and Non-Dipping Blood Pressure
NCT03128177
Treatment of Hypertension During Sleep
NCT03457168
Morning Versus Evening Dosing of Antihypertensive Medications: A Pilot Study to Assess Feasibility and Efficacy
NCT01965847
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Health
Healthy individuals with no known medical condition and taking no regular medication
Assessment of 24 hour blood pressure and arterial stiffness
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device
Acute kidney injury
Individuals with acute kidney injury as defined by KDIGO criteria
Assessment of 24 hour blood pressure and arterial stiffness
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device
Chronic kidney disease
Individuals with chronic kidney disease as defined by KDIGO criteria
Assessment of 24 hour blood pressure and arterial stiffness
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device
Small vessel vasculitis
Individuals with active small vessel vasculitis an diagnosed by a specialist physician
Assessment of 24 hour blood pressure and arterial stiffness
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device
Kidney transplant recipient
Individuals who have received a kidney transplant
Assessment of 24 hour blood pressure and arterial stiffness
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device
Kidney donor
Individuals who have donated a kidney for transplantation
Assessment of 24 hour blood pressure and arterial stiffness
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment of 24 hour blood pressure and arterial stiffness
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. CKD as defined by the Kidney Disease Outcome Quality Initiative (K/DOQI) classification
2. AKI as defined by the Kidney Disease Improving Global Outcomes (KDIGO) classification
3. Small vessel vasculitis
4. Kidney transplant recipient
5. Kidney donor We will also recruit a healthy control group from the community.
Exclusion Criteria
2. Lack of ability to provide informed consent
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Edinburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neeraj Dhaun, MBChB PhD
Role: PRINCIPAL_INVESTIGATOR
University of Edinburgh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Infirmary of Edinburgh
Edinburgh, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Neeraj Dhaun, MBChB PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AC19178
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.